No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Hepatology

Original research

No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir

Online download statistics by month:

Online download statistics by month: March 2020 to July 2022

	Abstract	Full	Pdf
Mar 2020	229	21	12
Apr 2020	1356	192	112
May 2020	514	50	29
Jun 2020	268	24	11
Jul 2020	139	16	7
Aug 2020	109	14	11
Sep 2020	87	24	19
Oct 2020	113	17	13
Nov 2020	117	13	7
Dec 2020	99	19	16
Jan 2021	723	93	60
Feb 2021	453	35	36
Mar 2021	238	26	21
Apr 2021	236	21	16
May 2021	45	11	12
Jun 2021	26	19	16
Jul 2021	12	9	8
Aug 2021	15	9	10
Sep 2021	24	15	6
Oct 2021	149	10	8
Nov 2021	127	22	4
Dec 2021	83	10	4
Jan 2022	151	23	8
Feb 2022	85	13	3
Mar 2022	109	22	8
Apr 2022	105	9	2
May 2022	151	4	2
Jun 2022	78	7	2
Jul 2022	79	8	2
Total	5920	756	465